Neuroone Medical Technologies Stock Price on February 16, 2024
| NMTC Stock | USD 0.76 0.02 2.70% |
Below is the normalized historical share price chart for Neuroone Medical Technologies extending back to August 01, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Neuroone Medical stands at 0.76, as last reported on the 22nd of December, with the highest price reaching 0.77 and the lowest price hitting 0.73 during the day.
If you're considering investing in Neuroone Stock, it is important to understand the factors that can impact its price. Neuroone Medical Tec has Sharpe Ratio of -0.0304, which conveys that the firm had a -0.0304% return per unit of risk over the last 3 months. Neuroone Medical exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Neuroone Medical's Risk Adjusted Performance of (0.02), standard deviation of 5.63, and Mean Deviation of 4.06 to check out the risk estimate we provide.
At present, Neuroone Medical's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Total Equity is expected to grow to about 26.8 K, whereas Liabilities And Stockholders Equity is forecasted to decline to about 3 M. . At present, Neuroone Medical's Price Sales Ratio is projected to increase significantly based on the last few years of reporting. Neuroone Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 18th of September 2017 | 200 Day MA 0.9246 | 50 Day MA 0.8131 | Beta 0.909 |
Neuroone |
Sharpe Ratio = -0.0304
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NMTC |
Estimated Market Risk
| 5.66 actual daily | 50 50% of assets are less volatile |
Expected Return
| -0.17 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Neuroone Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neuroone Medical by adding Neuroone Medical to a well-diversified portfolio.
Price Book 28.4476 | Enterprise Value Ebitda (2.10) | Price Sales 5.9616 | Shares Float 25.8 M | Wall Street Target Price 3.15 |
Neuroone Medical Main Headline on 16th of February 2024
Acquisition by Rosa David A of 663497 shares of Neuroone Med... by Rosa David A
Filed transaction by Neuroone Medical Technologies Director, Officer: Ceo And President. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Neuroone Medical Valuation on February 16, 2024
It is possible to determine the worth of Neuroone Medical on a given historical date. On February 16, 2024 Neuroone was worth 1.01 at the beginning of the trading date compared to the closed value of 1.03. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Neuroone Medical stock. Still, in general, we apply an absolute valuation method to find Neuroone Medical's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Neuroone Medical where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Neuroone Medical's related companies.
| Open | High | Low | Close | Volume | |
| 1.04 | 1.08 | 0.95 | 1.05 | 482,577 | |
02/16/2024 | 1.01 | 1.08 | 1.01 | 1.03 | 73,248 |
| 1.03 | 1.15 | 1.03 | 1.10 | 132,912 |
| Backtest Neuroone Medical | | | Neuroone Medical History | | | Neuroone Medical Valuation | Previous | Next |
Neuroone Medical Trading Date Momentum on February 16, 2024
| On February 20 2024 Neuroone Medical Technologies was traded for 1.10 at the closing time. The top price for the day was 1.15 and the lowest listed price was 1.03 . The trading volume for the day was 132.9 K. The trading history from February 20, 2024 was a factor to the next trading day price growth. The trading delta at closing time against the next closing price was 6.80% . The trading delta at closing time against the current closing price is 6.80% . |
Neuroone Medical Tec Fundamentals Correlations and Trends
By evaluating Neuroone Medical's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Neuroone Medical's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Neuroone financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Neuroone Medical Stock history
Neuroone Medical investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Neuroone is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Neuroone Medical Tec will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Neuroone Medical stock prices may prove useful in developing a viable investing in Neuroone Medical
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 26.8 M | 28.1 M | |
| Net Loss | -9 M | -9.4 M |
Neuroone Medical Stock Technical Analysis
Neuroone Medical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Neuroone Medical Period Price Range
Low | December 22, 2024
| High |
0.00 | 0.00 |
Neuroone Medical Technologies cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Neuroone Medical December 22, 2024 Market Strength
Market strength indicators help investors to evaluate how Neuroone Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Neuroone Medical shares will generate the highest return on investment. By undertsting and applying Neuroone Medical stock market strength indicators, traders can identify Neuroone Medical Technologies entry and exit signals to maximize returns
Neuroone Medical Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Neuroone Medical's price direction in advance. Along with the technical and fundamental analysis of Neuroone Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Neuroone to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.20) | |||
| Total Risk Alpha | (0.34) | |||
| Treynor Ratio | (0.25) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Neuroone Stock analysis
When running Neuroone Medical's price analysis, check to measure Neuroone Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neuroone Medical is operating at the current time. Most of Neuroone Medical's value examination focuses on studying past and present price action to predict the probability of Neuroone Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neuroone Medical's price. Additionally, you may evaluate how the addition of Neuroone Medical to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |